ENDRA Life Sciences Inc

General ticker "NDRA" information:

  • Sector: Health Care
  • Industry: Health Care Equipment & Supplies
  • Capitalization: $1.3M

ENDRA Life Sciences Inc does not follow the US Stock Market performance with the rate: -37.2%.

Estimated limits based on current volatility of 8.1%: low 4.98$, high 5.85$

Factors to consider:

  • Current price 99.2% below estimated low
  • Earnings for 9 months up through Q3 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [740.55$, 3041.27$]
  • 2024-12-30 to 2025-12-30 estimated range: [235.65$, 1058.10$]

Financial Metrics affecting the NDRA estimates:

  • Negative: Non-GAAP EPS, $ of -96.50 <= 0.10
  • Negative: Operating profit margin, % of -100 <= 1.03
  • Negative: Operating cash flow per share per price, % of -0.04 <= 2.35
  • Negative: negative Net income
  • Negative: Industry operating cash flow per share per price (median), % of -5.15 <= 3.85

Similar symbols

Short-term NDRA quotes

Long-term NDRA plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $11.50MM $13.16MM $10.52MM
Operating Income $-11.50MM $-13.16MM $-10.52MM
Non-Operating Income $0.27MM $-0.02MM $0.46MM
Interest Expense $0.00MM $0.02MM $0.00MM
R&D Expense $5.48MM $6.55MM $5.00MM
Income(Loss) $-11.23MM $-13.18MM $-10.06MM
Taxes $0.00MM $0.02MM $0.00MM
Profit(Loss) $-11.23MM $-13.20MM $-10.06MM
Stockholders Equity $10.78MM $7.20MM $5.66MM
Inventory $1.28MM $2.64MM $0.00MM
Assets $12.87MM $9.27MM $6.75MM
Operating Cash Flow $-11.12MM $-12.77MM $-9.55MM
Capital expenditure $0.04MM $0.20MM $0.03MM
Investing Cash Flow $-0.04MM $-0.20MM $-0.02MM
Financing Cash Flow $13.40MM $8.40MM $7.52MM
Earnings Per Share* $-5.47 $-4.57 $-1.11

* EPS are Split Adjusted, recent splits may be reflected with a delay.